Gyoonhee Han

3.6k total citations
123 papers, 2.8k citations indexed

About

Gyoonhee Han is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Gyoonhee Han has authored 123 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 28 papers in Organic Chemistry and 23 papers in Oncology. Recurrent topics in Gyoonhee Han's work include Histone Deacetylase Inhibitors Research (25 papers), Protein Degradation and Inhibitors (16 papers) and Ubiquitin and proteasome pathways (8 papers). Gyoonhee Han is often cited by papers focused on Histone Deacetylase Inhibitors Research (25 papers), Protein Degradation and Inhibitors (16 papers) and Ubiquitin and proteasome pathways (8 papers). Gyoonhee Han collaborates with scholars based in South Korea, United States and United Kingdom. Gyoonhee Han's co-authors include Steven M. Weinreb, Jong Soon Kang, Matthew G. LaPorte, Jee Sun Yang, Kang‐Yell Choi, Chulho Lee, Hwan Mook Kim, Kim M. Werner, Song‐Kyu Park and Sang‐Bae Han and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Gyoonhee Han

119 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gyoonhee Han South Korea 30 1.5k 886 474 263 236 123 2.8k
Jinliang Yang China 29 1.3k 0.9× 745 0.8× 566 1.2× 276 1.0× 149 0.6× 109 2.7k
Nam Doo Kim South Korea 32 1.8k 1.2× 454 0.5× 384 0.8× 274 1.0× 159 0.7× 102 2.9k
Siro Simizu Japan 32 2.0k 1.4× 502 0.6× 407 0.9× 352 1.3× 180 0.8× 117 2.8k
Hollis D. Showalter United States 31 1.8k 1.2× 853 1.0× 368 0.8× 161 0.6× 169 0.7× 89 3.1k
Rodolfo Márquez United Kingdom 27 1.7k 1.2× 1.2k 1.3× 332 0.7× 215 0.8× 297 1.3× 94 3.3k
Chunyong Ding China 31 1.8k 1.2× 576 0.7× 406 0.9× 543 2.1× 194 0.8× 110 3.1k
Ian P. Street Australia 31 1.9k 1.3× 998 1.1× 366 0.8× 212 0.8× 173 0.7× 57 3.0k
Shijun Wen China 36 2.0k 1.3× 1.2k 1.4× 511 1.1× 166 0.6× 200 0.8× 101 3.7k
Akira Asai Japan 33 1.8k 1.2× 938 1.1× 649 1.4× 275 1.0× 236 1.0× 132 3.0k
Gregory L. Kucera United States 32 1.4k 0.9× 628 0.7× 919 1.9× 332 1.3× 170 0.7× 73 2.7k

Countries citing papers authored by Gyoonhee Han

Since Specialization
Citations

This map shows the geographic impact of Gyoonhee Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gyoonhee Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gyoonhee Han more than expected).

Fields of papers citing papers by Gyoonhee Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gyoonhee Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gyoonhee Han. The network helps show where Gyoonhee Han may publish in the future.

Co-authorship network of co-authors of Gyoonhee Han

This figure shows the co-authorship network connecting the top 25 collaborators of Gyoonhee Han. A scholar is included among the top collaborators of Gyoonhee Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gyoonhee Han. Gyoonhee Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Jinkwan, Jinhyuk Kim, Xiang Fei, et al.. (2025). Structure-based optimization of TEAD inhibitors: Exploring a novel subpocket near Glu347 for the treatment of NF2-mutant cancer. Bioorganic Chemistry. 159. 108425–108425.
2.
3.
Han, Eui Jeong, Soo-Hwan Lee, Seokwon Lim, et al.. (2024). Propolis suppresses atopic dermatitis through targeting the MKK4 pathway. BioFactors. 51(1). e2119–e2119. 5 indexed citations
4.
Yu, Ji Eun, et al.. (2023). AB5-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus. Toxins. 15(7). 425–425. 3 indexed citations
5.
Lee, Chang Youn, Seahyoung Lee, Jiyun Lee, et al.. (2021). Suppressing Pyroptosis Augments Post-Transplant Survival of Stem Cells and Cardiac Function Following Ischemic Injury. International Journal of Molecular Sciences. 22(15). 7946–7946. 6 indexed citations
6.
Kim, Yonghyo, Yutaka Sugihara, Sung‐Min Cho, et al.. (2020). Identification and Validation of VEGFR2 Kinase as a Target of Voacangine by a Systematic Combination of DARTS and MSI. Biomolecules. 10(4). 508–508. 14 indexed citations
7.
Shin, Sun‐Hye, Jung Won Choi, Chang Youn Lee, et al.. (2019). Simultaneous Suppression of Multiple Programmed Cell Death Pathways by miRNA-105 in Cardiac Ischemic Injury. Molecular Therapy — Nucleic Acids. 14. 438–449. 29 indexed citations
8.
Lee, Jinhee, Ahyun Son, Paul Kim, et al.. (2018). RNA‐dependent chaperone (chaperna) as an engineered pro‐region for the folding of recombinant microbial transglutaminase. Biotechnology and Bioengineering. 116(3). 490–502. 9 indexed citations
9.
Choi, Ji Won, Siwon Kim, Jong‐Hyun Park, et al.. (2018). Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson’s Disease Therapy. Journal of Medicinal Chemistry. 62(2). 811–830. 60 indexed citations
10.
Choi, Eunhyun, Jae Hyun Kim, Hwan Mook Kim, et al.. (2013). Lactam‐Based HDAC Inhibitors for Anticancer Chemotherapy: Restoration of RUNX3 by Posttranslational Modification and Epigenetic Control. ChemMedChem. 9(3). 649–656. 5 indexed citations
11.
Han, Gyoonhee, et al.. (2013). The in vitro apoptotic effects of A248 and A1659, newly synthetic histone deacetylase inhibitors in oral cancer cells. Oral Diseases. 20(5). 482–489. 4 indexed citations
12.
Yang, Jee Sun, Bo‐Kyung Kim, Song‐Kyu Park, et al.. (2013). Synthesis and biological evaluation of novel aliphatic amido-quaternary ammonium salts for anticancer chemotherapy: Part II. European Journal of Medicinal Chemistry. 63. 621–628. 10 indexed citations
13.
Yang, Jee Sun, Bo‐Kyung Kim, Song‐Kyu Park, et al.. (2012). Design, synthesis and biological evaluation of novel aliphatic amido/sulfonamido-quaternary ammonium salts as antitumor agents. Bioorganic & Medicinal Chemistry. 21(3). 788–794. 5 indexed citations
14.
Yang, Jee Sun, et al.. (2011). Synthesis and biological evaluation of novel aliphatic amido-quaternary ammonium salts for anticancer chemotherapy: Part I. European Journal of Medicinal Chemistry. 46(7). 2861–2866. 15 indexed citations
15.
Jung, Hye Jin, Ki Hyun Kim, Nam Doo Kim, Gyoonhee Han, & Ho Jeong Kwon. (2010). Identification of a novel small molecule targeting UQCRB of mitochondrial complex III and its anti-angiogenic activity. Bioorganic & Medicinal Chemistry Letters. 21(3). 1052–1056. 23 indexed citations
16.
Choi, Eunhyun, Jung Eun Park, Jeong Jea Seo, et al.. (2010). Property based optimization of δ-lactam HDAC inhibitors for metabolic stability. Bioorganic & Medicinal Chemistry Letters. 20(22). 6808–6811. 12 indexed citations
17.
18.
Kang, Jong Soon, Chang Woo Lee, Kiho Lee, et al.. (2008). Inhibition of skin inflammation and atopic dermatitis by topical application of a novel ceramide derivative, K112PC-5, in mice. Archives of Pharmacal Research. 31(8). 1004–1009. 7 indexed citations
19.
Kim, Hwan Mook, Jaeseung Lim, Song-Kyu Park, et al.. (2007). Antitumor activity of cytokine-induced killer cells against human lung cancer. International Immunopharmacology. 7(13). 1802–1807. 50 indexed citations
20.
Kim, Hwan Mook, Sung Hee Hong, Myung Sook Kim, et al.. (2007). Modification of cap group in δ-lactam-based histone deacetylase (HDAC) inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(22). 6234–6238. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinliang Yang Breakdown of academic impact, for papers by Nam Doo Kim Breakdown of academic impact, for papers by Siro Simizu Breakdown of academic impact, for papers by Hollis D. Showalter Breakdown of academic impact, for papers by Rodolfo Márquez Breakdown of academic impact, for papers by Chunyong Ding Breakdown of academic impact, for papers by Ian P. Street Breakdown of academic impact, for papers by Shijun Wen Breakdown of academic impact, for papers by Akira Asai Breakdown of academic impact, for papers by Gregory L. Kucera
Rankless by CCL
2026